Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript November 6, 2024

Amphastar Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.96 EPS, expectations were $0.99.

Operator: Greetings and welcome to the Amphastar Pharmaceuticals Inc. Third Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that certain statements...